NCT00965328View on ClinicalTrials.gov

Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
KidneyAcute Renal FailureMultiple Organ Failure
Interventions
PROCEDURE

CVVH 4 to 2 L/h

CVVH is initiated at 4L/h and is converted to 2L/h after 60 min

PROCEDURE

CVVH 2 to 4L/h

CVVH is initiated at 2L/h and is converted to 4L/h after 60 min

Trial Locations (1)

1090AC

Onze Lieve Vrouwe Gasthuis, Amsterdam

All Listed Sponsors
lead

Onze Lieve Vrouwe Gasthuis

OTHER

NCT00965328 - Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration | Biotech Hunter | Biotech Hunter